Surgical treatment for metastatic lung cancer treated with bevacizumab
Shirato, T.; Aoki, T.; Yazawa, M.
Kyobu Geka. Japanese Journal of Thoracic Surgery 64(7): 579-581
2011
ISSN/ISBN: 0021-5252 PMID: 21766712 Document Number: 652194
62-year-old man with obstructive pneumonitis due to metastatic lung cancer admitted for surgery. Anticancer chemotherapy combined with bevacizumab had been canceled 8 weeks before surgery. Right lower lobectomy and wedge resection of right upper lobe were performed. Subcutaneous emphysema and prolonged air leakage appeared 5 days after surgery. Re-operation was performed 6 days after surgery, in order to control air leakage from suture line of the lung. The reason of prolonged air leakage was possibly the side effect of bevacizumab.
Document emailed within 1 workday
Related Documents
Hasegawa, J.; Noura, S.; Hirota, M.; Matsumura, T.; Yasuyama, A.; Takata, A.; Koga, C.; Murakami, M.; Kameda, C.; Oda, N.; Kawabata, R.; Morishima, H.; Shimizu, J.; Matsunami, N. 2016: A Case of Metastatic Colorectal Cancer Refractory to Standard Chemotherapies Treated with TAS-102 with Bevacizumab Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(12): 2289-2291Takano, J.; Matsuhashi, N.; Takahashi, T.; Tanahashi, T.; Matsui, S.; Imai, H.; Tanaka, Y.; Yamaguchi, K.; Yoshida, K. 2018: A Case of Metastatic Colorectal Cancer with Brain Metastasis Treated with Combined TFTD and Bevacizumab Therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(2): 318-320
Otani, Y.; Kondo, T.; Saito, R.; Matsumura, Y.; Ohura, H.; Hirose, M.; Horikoshi, A.; Sado, T.; Sugita, M.; Okaniwa, G. 1995: Surgical treatment of metastatic lung tumor from colorectal cancer Kyobu Geka. Japanese Journal of Thoracic Surgery 48(9): 735-740
Arakawa, S.; Horiguchi, A.; Tomishige, H.; Kawabe, N.; Nagata, H.; Ishihara, S.; Ito, M.; Asano, Y.; Ito, R.; Isetani, M.; Shimizu, K.; Kamio, K.; Kawai, T.; Yasuoka, H.; Imaeda, Y. 2018: Safety and Efficacy of TAS-102 with Bevacizumab for the Treatment of Unresectable Metastatic Colorectal Cancer - A Case Report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(4): 649-651
Chen, C.; Sun, P.; Ye, S.; Weng, H.-W.; Dai, Q.-S. 2014: Hypertension as a predictive biomarker for efficacy of bevacizumab treatment in metastatic colorectal cancer: a meta-analysis Journal of Buon: Official Journal of the Balkan Union of Oncology 19(4): 917-924
Yabe, N.; Murai, S.; Shimizu, H.; Kitasato, K.; Yoshikawa, T.; Oto, I.; Nakadai, J.; Hasegawa, H.; Kitagawa, Y. 2013: Recurrent rectal cancer with multiple liver and lung metastases treated effectively with oxaliplatin and capecitabine plus bevacizumab chemotherapy-a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 1834-1836
Denić, K.; Tarabar, D.; Obradovic, S.; Ristić, M.; Spasić, J.; Radosavljević, D.; Ugrešić, N. 2016: Biochemical liver function test parameter levels in relation to treatment response in liver metastatic colorectal patients treated with FOLFOX4 with or without bevacizumab Srpski Arhiv Za Celokupno Lekarstvo 144(11-12): 615-620
Ishiura, Y.; Yamamoto, H.; Terasaki, Y.; Ishida, Y.; Tohge, M.; Segawa, M.; Kusajima, Y.; Saitoh, K.; Ishikawa, M.; Hirokami, N.; Kasahara, K.; Fujimura, M. 2011: Bevacizumab with platinum chemotherapy as 6th-line treatment in a case of non-small-cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(13): 2631-2633
Ohata, M. 1993: Surgical treatment for metastatic lung tumors--with special references to colorectal lung metastases Human Cell 6(2): 88-93
Pearce, M.B.; Vaughn, C.C. 1970: Surgical management of metastatic cancer in the lung Arizona Medicine 27(1): 65-67
Imaizumi, H.; Ishibashi, K.; Okada, N.; Tajima, Y.; Amano, K.; Hatano, S.; Kuwabara, K.; Sobajima, J.; Ishiguro, T.; Ohsawa, T.; Kumamoto, K.; Kumagai, Y.; Haga, N.; Ishida, H. 2012: Clinical outcomes in refractory colorectal cancer patients with wild-type K-ras treated with bevacizumab and oxaliplatin-based chemotherapy as a first-line treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 2185-2188
Kamiyoshihara, M.; Hirai, T.; Kawashima, O.; Sakata, S.; Morishita, Y. 1998: Analyses on the long-term prognosis of surgical treatment for primary lung cancer in the elderly patients of 75 or over years old: how should be treated the non-recurrent death? Kyobu Geka. Japanese Journal of Thoracic Surgery 51(2): 112-115
Miyake, Y.; Ikeda, K.; Murakami, M.; Oka, Y.; Nezu, R.; Kurokawa, E.; Kikkawa, N. 2015: Two Cases of Bowel Perforation during Chemotherapy with Bevacizumab to Metastatic Rectal Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(Suppl 1): 75-78
Nakahashi, H.; Miyazaki, K.; Kuda, T.; Takeo, S.; Nagashima, A.; Ishida, T.; Yasumoto, K.; Sugimachi, K. 1988: Surgical treatment of metastatic tumors in the lung Nihon Kyobu Geka Gakkai 36(1): 63-68
Miyazawa, N. 1983: Surgical treatment of metastatic tumor in the lung Gan no Rinsho. Japan Journal of Cancer Clinics 29(6): 572-577
Koike, J.; Ushigome, M.; Funahashi, K.; Shiokawa, H.; Kaneko, T.; Arai, K.; Matsuda, S.; Kagami, S.; Suzuki, T.; Kurihara, A.; Shimada, H.; Kaneko, H. 2014: Significance of KRAS mutation in patients receiving mFOLFOX6 with or without bevacizumab for metastatic colorectal cancer Hepato-Gastroenterology 61(136): 2222-2226
Yamamoto, Y.; Hirata, T.; Fukuse, T.; Yokomise, H.; Ike, O.; Mizuno, H.; Wada, H.; Hitomi, S.; Nakamura, T.; Shimizu, Y. 1996: Diagnosis and surgical treatment of metastatic lung tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(10): 1248-1254
Sehnalová, I.; Říhová, B.; Demlová, R. 2019: Bevacizumab treatment in metastatic colorectal carcinoma - an economic perspective Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 68(2): 43-47
Nerich, V.; Bazan, F.; Compagnat, F.; Dobi, E.; Villanueva, C.; Chaigneau, Lïc.; Perrin, S.; Voidey, A.; Pivot, X.; Limat, S. 2012: First-line bevacizumab plus taxane-based chemotherapy for metastatic breast cancer: cost-minimisation analysis Anticancer Research 32(8): 3547-3552
Harvey, J.C.; Beattie, E.J. 1993: Surgical treatment of solitary and multiple metastatic tumors to the lung Comprehensive Therapy 19(5): 238-241